Migraine Research Foundation 2010 Grants Awarded

Teri Robert @trobert Health Guide
  • One of the biggest issues holding back new Migraine treatments is lack of adequate Migraine research funding. The kind of basic research usually funded by the NIH is sorely needed before pharmaceutical companies can look at new types of treatment. This is where the Migraine Research Foundation (MRF) comes in. With all of their expenses underwritten, every dollar donated to them goes directly to Migraine research funding.


    Each year, the MRF asks researchers to submit applications for Migraine research funding. Their 2010 research grants were recently awarded. The seven grants were selected through a competitive process from an unprecedented 40 proposals received from nine countries.

    Add This Infographic to Your Website or Blog With This Code:


    This year's grantees will explore innovative inquiries in the areas of pediatric migraine, chronic migraine, migraine in women, and basic science. Cathy Glaser, co-founder and President of MRF, said,

    "We are thrilled with the caliber of the investigations in these proposals. They represent novel clinical and bench science approaches to unraveling the mysteries of migraine. In just four years, we've awarded 23 grants to some of the most promising investigators - and we know they're going to make a difference."

    The seven MRF grant recipients and their research are:

    • Trent Anderson, Ph.D., University of Arizona College Of Medicine-Phoenix
      Neurosteroid Regulation of Cortical Spreading Depression
    • Brandon Aylward, Ph.D., and Scott Powers, Ph.D., Cincinnati Children's Hospital Medical Center
      The Multidimensional Impact of Migraine in Adolescents Presenting to Specialty Care
    • Alexandre DaSilva, DDS, DMedSc, University of Michigan School of Dentistry
      Endogenous Opioid Mechanisms in Chronic Migraine
    • Richard Kraig, Ph.D., MD, The University of Chicago Medical Center
      Preclinical Development of Nasal Insulin as a Therapy for Chronic Migraine
    • Todd Smitherman, Ph.D., University of Mississippi
      Efficacy of Behavioral Insomnia Treatment for Chronic Migraine: A Randomized Controlled Pilot Study
    • Patric Stanton, Ph.D., New York Medical College
      N-Methyl-D-Aspartate Receptor Glycine Coagonist Site Modulation as a Potential Treatment for Migraine
    • Colin Willis, Ph.D., University of New England College of Osteopathic Medicine
      Mechanisms of Blood-Brain Barrier Dysfunction Induced Medication Overuse Headache

    Dr. Joel Saper, founder of the Michigan Head Pain & Neurological Institute, Ann Arbor, MI, and Chair of MRF's medical advisory board, commented,

    "This year's recipients continue to demonstrate the highly innovative thinking which MRF encourages. The medical community is grateful to the foundation and the investigators it supports."

    The MRF medical advisory board of distinguished scientists, chaired by Dr. Saper, also includes Dr. Rami Burstein (Harvard Medical School, Boston, MA), Dr. F. Michael Cutrer (Mayo Clinic, Rochester, MN), Dr. David W. Dodick (Mayo Clinic, Phoenix, AZ), Dr. Peter J. Goadsby (University of California at San Francisco, CA), Dr. Richard Lipton (Albert Einstein College of Medicine, Bronx, NY), Dr. Fred Sheftell (New England Center for Headache, Stamford, CT), and Dr. Stephen D. Silberstein (Jefferson University Hospital, Philadelphia, PA).


  • Add This Infographic to Your Website or Blog With This Code:

    For more information about the MRF, or to make a donation, visit their web site.


    Live well,

     

     

    Puz-only-btn

     

    Get the latest Migraine and headache news, informational articles, tips for living well, and more in my free weekly newsletter. To subscribe, CLICK HERE.

     


     

    Follow me on    or 


     

    BlogWithIntegrity.com

     

     

     

     

     

     

    Page copy protected against web site content infringement by Copyscape© Teri Robert, 2011
    Last updated January 24, 2011.

Published On: January 24, 2011